These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27575555)

  • 1. Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.
    Pluznick JL
    Kidney Int; 2016 Dec; 90(6):1191-1198. PubMed ID: 27575555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota-derived short-chain fatty acids and kidney diseases.
    Li L; Ma L; Fu P
    Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiome and AKI: Roles of the Immune System and Short-Chain Fatty Acids.
    Gharaie S; Noel S; Rabb H
    Nephron; 2020; 144(12):662-664. PubMed ID: 32721962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
    Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
    Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered microRNA regulation of short chain fatty acid receptors in the hypertensive kidney is normalized with hydrogen sulfide supplementation.
    Weber GJ; Foster J; Pushpakumar SB; Sen U
    Pharmacol Res; 2018 Aug; 134():157-165. PubMed ID: 29909116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between gut microbiota and short chain fatty acids in the renal calcium oxalate stones disease.
    Liu Y; Jin X; Hong HG; Xiang L; Jiang Q; Ma Y; Chen Z; Cheng L; Jian Z; Wei Z; Ai J; Qi S; Sun Q; Li H; Li Y; Wang K
    FASEB J; 2020 Aug; 34(8):11200-11214. PubMed ID: 32645241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications.
    Muralitharan RR; Jama HA; Xie L; Peh A; Snelson M; Marques FZ
    Hypertension; 2020 Dec; 76(6):1674-1687. PubMed ID: 33012206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfaction in the kidney: 'smelling' gut microbial metabolites.
    Natarajan N; Pluznick JL
    Exp Physiol; 2016 Apr; 101(4):478-81. PubMed ID: 26238273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response.
    Huang W; Zhou L; Guo H; Xu Y; Xu Y
    Metabolism; 2017 Mar; 68():20-30. PubMed ID: 28183450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.
    Gong J; Noel S; Pluznick JL; Hamad ARA; Rabb H
    Semin Nephrol; 2019 Jan; 39(1):107-116. PubMed ID: 30606403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment.
    Yang F; Chen H; Gao Y; An N; Li X; Pan X; Yang X; Tian L; Sun J; Xiong X; Xing Y
    Biomed Pharmacother; 2020 Oct; 130():110503. PubMed ID: 34321175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.
    Koh A; De Vadder F; Kovatcheva-Datchary P; Bäckhed F
    Cell; 2016 Jun; 165(6):1332-1345. PubMed ID: 27259147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology.
    Natarajan N; Pluznick JL
    Am J Physiol Cell Physiol; 2014 Dec; 307(11):C979-85. PubMed ID: 25273884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism.
    Morrison DJ; Preston T
    Gut Microbes; 2016 May; 7(3):189-200. PubMed ID: 26963409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease.
    Makki K; Deehan EC; Walter J; Bäckhed F
    Cell Host Microbe; 2018 Jun; 23(6):705-715. PubMed ID: 29902436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of microbially derived short-chain fatty acids on intestinal homeostasis, metabolism, and neuropsychiatric disorder.
    Xiao S; Jiang S; Qian D; Duan J
    Appl Microbiol Biotechnol; 2020 Jan; 104(2):589-601. PubMed ID: 31865438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation.
    Magliocca G; Mone P; Di Iorio BR; Heidland A; Marzocco S
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Gut Microbiota and Its Metabolites in Hypertension of Developmental Origins: Exploring Differences between Fructose and Antibiotics Exposure.
    Hsu CN; Chan JYH; Wu KLH; Yu HR; Lee WC; Hou CY; Tain YL
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment.
    Li Y; Su X; Gao Y; Lv C; Gao Z; Liu Y; Wang Y; Li S; Wang Z
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165764. PubMed ID: 32169506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.